Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children
- 373 Downloads
The aim of this study is to investigate the role of pattern reversal visual evoked potentials (pVEPs) in the screening and monitoring of optic pathway gliomas (OPGs) in children with and without neurofibromatosis type 1.
A review of the English literature published between 1980 and 2012 was performed, with comparison of results of retro- and prospective studies.
Pattern reversal VEPs have a high sensitivity (85.7–100 %) for the diagnosis of OPGs, moreover they are safe and cost-effective. Conversely, they have a low specificity (43–83 %) and are not widely available. Besides, pattern reversal VEP results can be unreliable in young children, because of the need for a good cooperation. The studies that were analyzed have drawbacks, including the small sample size, the retrospective design, the differences in gold standard for diagnosis, the different interpretation of small changes in VEP results and the lack of control groups.
There is still debate about the gold standard for the screening and follow-up of OPGs. The added value of pVEPs to the ophthalmic examination is controversial. Randomized controlled trials or prospective multicentre studies are necessary to assess with sufficient accuracy the sensitivity and specificity of pattern reversal VEPs in the screening for OPGs and its follow-up.
KeywordsOptic pathway glioma Neurofibromatosis type 1 Visual evoked potentials Children
Conflict of interest
- 13.Sharif S, Upadhyaya M, Ferner R, Majouni E, Shenton A, Baser M, Thakker N, Evans DG (2011) A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations. J Med Genet 48:256–260CrossRefPubMedGoogle Scholar
- 17.Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a retrospective analysis. Neuro Oncol 14:790–797CrossRefPubMedGoogle Scholar
- 19.Odom JV, Bach M, Brigell M, Holder GE, McCulloch DL, Tormens AP, Vaegan (2010) ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol 120:111–119Google Scholar
- 25.Cohen ME, Duffner PK (1983) Visual-evoked responses in children with optic gliomas, with and without neurofibromatosis. Child Brain 10:99–111Google Scholar
- 28.Wenzel D, Brandl U, Beck JD, Cedzich C, Albert F (1988) Visual evoked potentials in tumors from orbita to occipital lobe in childhood. Neurosurg Rev 11:279–286Google Scholar
- 41.Falsini B, Ziccardi L, Lazzareschi I, Ruggiero A, Placentino L, Dickmann A, Liotti L, Piccardi M, Balestrazzi E, Colosimo C, Di Rocco C, Riccardi R (2008) Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol 88:87–96CrossRefPubMedGoogle Scholar